Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL Debt - Unamortized Discount (Premium) and Issuance Costs, Net

Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies

Abbott logo
AbbottABT
$47M-11.3%
Danaher logo
DanaherDHR
——
Revvity logo
RevvityRVTY
——
Charles River Laboratories logo
Charles River LaboratoriesCRL
——
Bruker logo
BrukerBRKR
——
Zoetis logo
ZoetisZTS
——

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNet.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's debt - unamortized discount (premium) and issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's debt - unamortized discount (premium) and issuance costs, net?
QuidelOrtho Corporation (QDEL) reported debt - unamortized discount (premium) and issuance costs, net of $18.8M in Q1 2026.
How has QuidelOrtho Corporation's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
QuidelOrtho Corporation's debt - unamortized discount (premium) and issuance costs, net increased by 283.7% year-over-year, from $4.9M to $18.8M.
What is the long-term trend for QuidelOrtho Corporation's debt - unamortized discount (premium) and issuance costs, net?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's debt - unamortized discount (premium) and issuance costs, net has grown at a 56.5% compound annual growth rate (CAGR), from $8M to $19.6M.
What does debt - unamortized discount (premium) and issuance costs, net mean?
This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.